What is BIB's market cap?

$97.13M, based on the Sep 28 close of $115.63.

Does ProShares Ultra NASDAQ Biotechnology pay a dividend?

Yes. The latest regular dividend was $0.0826 per share (ex-date Sep 23), an annualised yield of 0.29%.

NASDAQ · BIB

ProShares Ultra NASDAQ Biotechnology (BIB)

$115.63+1.06%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$115.63▲ 98.15% in range

Sep 29, 2025Low $58.35 · High $126.22Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

ProShares Ultra NASDAQ Biotechnology closed at $115.63 on Sep 28, up 1.06%, 8.4% below its 52-week closing high. Volume of 10.0K shares was 1.16× its 20-day average (close to normal).

Split-adjusted performance: -6.1% over one month, +56.7% over six months, +108.5% over one year.

Short interest was 4.1K shares at the Sep 15 settlement, down 52.9% from the prior report (1.0 days to cover).

Market cap$97.1M840.0K shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield0.29%$0.0826 last paid

52-week range55.46 – 126.22−8.4% from high

Volume10.0K1.16× 20-day avg

Volatility · 60d46.5%Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W +1.9%1M −6.1%3M +15.1%6M +56.7%YTD +44.9%1Y +108.5%3Y +139.2%5Y +13.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short4.1K−52.9% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d49.1%of daily volume

News about ProShares Ultra NASDAQ Biotechnology

All news →

No recent articles focused on ProShares Ultra NASDAQ Biotechnology.

Quick answers

What is BIB's market cap?: $97.13M, based on the Sep 28 close of $115.63.
Does ProShares Ultra NASDAQ Biotechnology pay a dividend?: Yes. The latest regular dividend was $0.0826 per share (ex-date Sep 23), an annualised yield of 0.29%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology